Dataciencia

Colección SciELO Chile

Introduction of an ancient founder glycoprotein VI mutation into the Chilean population

Indexado

WoS	WOS:000913702900007
Scopus	SCOPUS_ID:85143119772

DOI

10.1182/BLOODADVANCES.2022008531

Año

2022

Tipo

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras

Revista

Revista	ISSN
Blood Advances	2473-9529

Métricas Externas

PlumX	Altmetric	Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Plumx: https://plumanalytics.com/learn/about-metrics/
Altmetric: https://www.altmetric.com/about-altmetrics/what-are-altmetrics/
Dimensions: https://www.dimensions.ai/why-dimensions/

Disciplinas de Investigación

WOS
Hematology

Scopus
Sin Disciplinas

SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional

Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.

Autores - Afiliación

Ord.	Autor	Género	Institución - País
1	Dalby, Amanda	Mujer	University of Birmingham, College of Medical and Dental Sciences - Reino Unido Univ Birmingham - Reino Unido
2	MEZZANO-ABEDRAPO, DIEGO ANTONIO	Hombre	Pontificia Universidad Católica de Chile - Chile Pontificia Univ Chile - Chile
3	Rivera, J.	Hombre	Centro Regional de Hemodonacion - España UNIV MURCIA - España
4	Watson, S	Hombre	University of Birmingham, College of Medical and Dental Sciences - Reino Unido Univ Birmingham - Reino Unido
5	Morgan, Neil	Hombre	University of Birmingham, College of Medical and Dental Sciences - Reino Unido Univ Birmingham - Reino Unido

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento

Fuente
Fondo Nacional de Desarrollo Científico y Tecnológico
European Regional Development Fund
Instituto de Salud Carlos III
British Heart Foundation
British Heart Foundation Chair
Agencia Nacional de Investigación y Desarrollo
ANID/FONDECYT Chile
SETH
Spanish Society of Thrombosis and Haemostasis
B.H.F Accelerator Award
Spanish Society of Thrombosis and Haemostasis (SETH, Ayuda GEAPC)
Instituto de Salud Carlos III (ISCIII) Feder

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos

Agradecimiento
Acknowledgments: The authors would like to acknowledge help from the DNA sequencing services by the School of Biosciences, University of Birmingham, United Kingdom. The work in the author’s laboratories is supported by the British Heart Foundation (FS/18/ 11/33443) (NVM), S.P.W. holds a British Heart Foundation Chair (CH03/003). A.D. is supported by a B.H.F Accelerator Award (AA/18/2/34218). D.M. is supported by Grant 1181681, ANID/ FONDECYT Chile. J.R. research is supported by grants from Instituto de Salud Carlos III (ISCIII) & Feder (PI20/00926 and PMP21/00052) and the Spanish Society of Thrombosis and Haemostasis (SETH, Ayuda GEAPC).
The authors would like to acknowledge help from the DNA sequencing services by the School of Biosciences, University of Birmingham, United Kingdom. The work in the author's laboratories is supported by the British Heart Foundation (FS/18/11/33443) (NVM) , S.P.W. holds a British Heart Foundation Chair (CH03/003) . A.D. is supported by a B.H.F Accelerator Award (AA/18/2/34218). D.M. is supported by Grant 1181681, ANID/FONDECYT Chile. J.R. research is supported by grants from Instituto de Salud Carlos III (ISCIII) & Feder (PI20/00926 and PMP21/00052) and the Spanish Society of Thrombosis and Haemostasis (SETH, Ayuda GEAPC).

Agradecimiento

Acknowledgments: The authors would like to acknowledge help from the DNA sequencing services by the School of Biosciences, University of Birmingham, United Kingdom. The work in the author’s laboratories is supported by the British Heart Foundation (FS/18/ 11/33443) (NVM), S.P.W. holds a British Heart Foundation Chair (CH03/003). A.D. is supported by a B.H.F Accelerator Award (AA/18/2/34218). D.M. is supported by Grant 1181681, ANID/ FONDECYT Chile. J.R. research is supported by grants from Instituto de Salud Carlos III (ISCIII) & Feder (PI20/00926 and PMP21/00052) and the Spanish Society of Thrombosis and Haemostasis (SETH, Ayuda GEAPC).

The authors would like to acknowledge help from the DNA sequencing services by the School of Biosciences, University of Birmingham, United Kingdom. The work in the author's laboratories is supported by the British Heart Foundation (FS/18/11/33443) (NVM) , S.P.W. holds a British Heart Foundation Chair (CH03/003) . A.D. is supported by a B.H.F Accelerator Award (AA/18/2/34218). D.M. is supported by Grant 1181681, ANID/FONDECYT Chile. J.R. research is supported by grants from Instituto de Salud Carlos III (ISCIII) & Feder (PI20/00926 and PMP21/00052) and the Spanish Society of Thrombosis and Haemostasis (SETH, Ayuda GEAPC).